Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Asker Healthcare Group AB ( (SE:ASKER) ) has issued an announcement.
Asker Healthcare Group has announced the acquisition of Kirstine Hardam A/S, a prominent distributor of medical supplies in Denmark, which will enhance Asker’s presence in the Danish market. This strategic acquisition, subject to regulatory approvals and expected to close in the fourth quarter of 2025, aims to integrate Hardam’s expertise in ostomy, wound care, nutrition, and incontinence care into Asker’s portfolio, potentially strengthening its market position and operational capabilities.
The most recent analyst rating on (SE:ASKER) stock is a Buy with a SEK100.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.
More about Asker Healthcare Group AB
Asker Healthcare Group is a European healthcare company that partners with caregivers and patients across Europe, providing medical products and solutions. The group focuses on improving patient outcomes, reducing the total cost of care, and ensuring a sustainable value chain. Asker Healthcare combines the entrepreneurial spirit of local companies with the knowledge of a large group, employing over 4,000 people across 17 countries with revenues of SEK 16 billion.
Average Trading Volume: 839,648
Current Market Cap: SEK41.36B
For a thorough assessment of ASKER stock, go to TipRanks’ Stock Analysis page.